Feasibility of cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) for advanced peritoneal surface tumors during the COVID-19 pandemic: A single-institution experience.
Shannon N RadomskiIsabella FlorissiHamza KhanAmn SiddiqiDane C PaneitzFabian M JohnstonJonathan B GreerPublished in: Journal of surgical oncology (2022)
Despite presenting with more extensive disease, patients treated with CRS-HIPEC during the height of the COVID-19 pandemic had comparable perioperative outcomes to patients treated prepandemic.